Combined Transapical Aortic Valve Replacement and Minimally Invasive Direct Coronary Bypass Grafting—A New Concept for Selected High-Risk Patients
DOI:
https://doi.org/10.1532/HSF98.20101060Abstract
Background: Transcatheter aortic valve implantation and minimally invasive direct coronary artery bypass (MIDCAB) procedures are both off-pump treatment options for a subset of higher-risk patients. We present a new, minimally invasive surgical concept involving combining the procedures and performing them through the same thoracic access in a patient with a vascular disorder.
Case Report: We report on a 78-year-old patient with symptomatic calcified aortic stenosis and a critical lesion of the left anterior descending coronary artery. In addition, Rendu-Osler-Weber disease was diagnosed. He was successfully treated with combined off-pump transapical, transcatheter aortic valve implantation and MIDCAB grafting. The initial postoperative recovery was good; however, the patient died 3 months postoperatively from septic complications.
Conclusion: This combined procedure performed through the same anterolateral incision was technically feasible and may be a promising, minimally invasive approach for selected patients.
References
Cheung A, Wong DR, Ye J, Webb JG, Lichtenstein SV. 2008. Combined off-pump transapical transcatheter aortic valve implantation and MIDCAB revascularization. ISMICS 2008 Annual Scientific Meeting Abstracts-Video. Innovations 3:115.nGallitelli M, Pasculli G, Fiore T, Carella A, Sabbà C. 2006. Emergencies in hereditary haemorrhagic telangiectasia. QJM 99:15-22.nGerckens U, Mudra H, Schuler GC, et al. 2010. Comparison of transfemoral and transapical aortic valve replacement: results of the German registry on transcatheter aortic valve implantation. J Am Coll Cardiol 55:A216.E2053.nGrube E, Schuler G, Buellesfeld L, et al. 2007. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50:69-76.nGuttmacher AE, Marchuk DA, White RI Jr. 1995. Hereditary hemorrhagic telangiectasia. N Engl J Med 333:918-24.nHimbert D, Descoutures F, Al-Attar N, et al. 2009. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol 54:303-11.nHolzhey DM, Jacobs S, Mochalski M, et al. 2007. Seven-year follow-up after minimally invasive direct coronary artery bypass: experience with more than 1300 patients. Ann Thorac Surg 83:108-14.nIshikawa S, Oshima K, Aizaki M, Takahashi T, Hasegawa Y, Morishita Y. 2004. A second mitral valve replacement in a patient with hereditary hemorrhagic telangiectasia (Osler's disease). Jpn Heart J 45:885-8.nRadu C, Reich DL, Tamman R. 1992. Anesthetic considerations in a cardiac surgical patient with Osler-Weber-Rendu disease. J Cardiothorac Vasc Anesth 6:461-4.nSakata Y, Anzai T, Iijima T, et al. 1992. Mitral valve replacement in a patient with hereditary hemorrhagic telangiectasia [in Japanese]. Kyobu Geka 45:1024-6.nSeike Y, Sato H, Nagashima M, et al. 2005. Aortic valve replacement for the patient with Osler-Rendu-Weber disease [in Japanese]. Kyobu Geka 58:1141-4.nSvensson LG, Dewey T, Kapadia S, et al. 2008. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 86:46-54; discussion 54-5.nWalther T, Chu MW, Mohr FW. 2008. Transcatheter aortic valve implantation: time to expand? Curr Opin Cardiol 23:111-6.n
